These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 1053754)

  • 1. Inhibitory spectrum of a bacteriocinlike substance (mutacin) produced by some strains of Streptococcus mutans.
    Hamada S; Ooshima T
    J Dent Res; 1975; 54(1):140-5. PubMed ID: 1053754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutacins from Streptococcus mutans UA159 are active against multiple streptococcal species.
    Hossain MS; Biswas I
    Appl Environ Microbiol; 2011 Apr; 77(7):2428-34. PubMed ID: 21296932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of bacteriocin-like substances by human oral streptococci.
    Fabio U; Bondi M; Manicardi G; Messi P; Neglia R
    Microbiologica; 1987 Oct; 10(4):363-70. PubMed ID: 3695984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriocin production by Streptococcus milleri.
    Drucker DB; McKillop CM
    Can J Microbiol; 1982 Mar; 28(3):278-83. PubMed ID: 7083071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of mutacin b, an antibacterial substance produced by Streptococcus mutans strain BHT.
    Delisle AL
    Microbios; 1986; 46(186):21-8. PubMed ID: 3526096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and properties of extracellular mutacin, a bacteriocin from Streptococcus sobrinus.
    Loyola-Rodriguez JP; Morisaki I; Kitamura K; Hamada S
    J Gen Microbiol; 1992 Feb; 138(2):269-74. PubMed ID: 1564438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Purification of mutacin].
    Yang L; Xu XF; Yang BX; Liu W; Li S
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2010 Oct; 28(5):565-9. PubMed ID: 21179700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius.
    Dempster RP; Tagg JR
    Arch Oral Biol; 1982; 27(2):151-7. PubMed ID: 7044350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of propionibacterium acnes by bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivarius.
    Bowe WP; Filip JC; DiRienzo JM; Volgina A; Margolis DJ
    J Drugs Dermatol; 2006 Oct; 5(9):868-70. PubMed ID: 17039652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial characterisation of the inhibitory substances produced by Streptococcus oralis and related species.
    Willcox MD; Drucker DB
    Microbios; 1988; 55(224-225):135-45. PubMed ID: 3216798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic basis for mutacin N and of its relationship to mutacin I.
    Hale JD; Balakrishnan B; Tagg JR
    Indian J Med Res; 2004 May; 119 Suppl():247-51. PubMed ID: 15232205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutacin production in Streptococcus mutans genotypes isolated from caries-affected and caries-free individuals.
    Kamiya RU; Napimoga MH; Rosa RT; Höfling JF; Gonçalves RB
    Oral Microbiol Immunol; 2005 Feb; 20(1):20-4. PubMed ID: 15612940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutacin II, a bactericidal antibiotic from Streptococcus mutans.
    Chikindas ML; Novák J; Driessen AJ; Konings WN; Schilling KM; Caufield PW
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2656-60. PubMed ID: 8592997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antimicrobial activity of two new mutacins.
    Nicolas GG; LaPointe G; Lavoie MC
    West Indian Med J; 2010 Dec; 59(6):602-6. PubMed ID: 21702231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and biochemical characterization of mutacin VSM43 isolated from human oral Streptococcus mutans VSM43.
    Ahmad S; Rasool SA
    Pak J Pharm Sci; 2003 Jul; 16(2):43-50. PubMed ID: 16414575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriocin-like inhibitory activity associated with beta-hemolytic strains of Streptococcus salivarius.
    Tompkins GR; Tagg JR
    J Dent Res; 1987 Aug; 66(8):1321-5. PubMed ID: 3476599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors.
    Tagg JR; Bannister LV
    J Med Microbiol; 1979 Nov; 12(4):397-411. PubMed ID: 41951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriocin patterns of strains belonging to various serotypes of Streptococcus mutans.
    Rogers AH
    Arch Oral Biol; 1976; 21(4):243-9. PubMed ID: 1068659
    [No Abstract]   [Full Text] [Related]  

  • 19. [The inhibition effect of recombinant Streptococcus mutans JH1140 containing urease gene on Streptococcus mutans UA159].
    Rui X; Feng XP
    Shanghai Kou Qiang Yi Xue; 2010 Jun; 19(3):281-4. PubMed ID: 20635041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes bacteriocinlike inhibitory substance.
    Tagg JR; van de Rijn I
    J Clin Microbiol; 1991 Apr; 29(4):848-9. PubMed ID: 1890190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.